Some studies suggested a link between OSA and abnormal glucose metabolism prior to the manifestation of diabetes [41, 42], and further demonstrated that two pathophysiological processes of OSA (SF and IH) could increase circulating glucose by decreasing insulin sensitivity and reducing glucose effectiveness [13, 43–45]. This evidence concerns the gene INS and diabetes mellitus.